Aug 03, 2022
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.00 to $0.00.
The split itself did not change the total investment value.
HAVN Life Sciences Inc. (HAVLF) trades on the Other OTC in the Biotechnology industry.
HAVN Life Sciences Inc. company overviewThe latest split shown was on August 3, 2022. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
This history records one reverse split, on August 3, 2022.
Already premium? Sign in